Live Breaking News & Updates on Femoropopliteal Occlusive Disease

1. There was no significant increase in mortality between the paclitaxel-coated and control devices in both the intention-to-treat and as-treated analyses groups. Evidence Rating Level: 1 (Excellent) Study Rundown: The safety of paclitaxel-coated devices for femoropopliteal disease has been well-studied; however, a 2018 meta-analysis raised concerns about increased mortality risk with paclitaxel. This meta-analysis aimed to provide ....

Minute Medicine Inc , Rating Level , Paclitaxel Coated Devices , Peripheral Artery , Femoropopliteal Disease , Femoropopliteal Occlusive Disease ,